Literature DB >> 1538421

Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin.

D Platt1, A Raz.   

Abstract

CONTEXT: Studies have shown that the galactoside-containing simple sugars and anti-galactoside-binding lectin antibodies may affect experimental tumor cell metastasis. However, the limited number of reagents used thus far necessitate further observations.
PURPOSE: Natural citrus pectin (CP) and pH-modified CP (MCP), rich in galactose residues, were used to study the involvement of carbohydrates containing galactoside residues in cellular interaction in vitro and in lung colonization in vivo of B16-F1 melanoma cells.
METHODS: B16-F1 melanoma cells were incubated with various concentrations of CP and MCP. Their ability to form homotypic aggregation in vitro and tumor lung colonization in vivo in 8-week-old female C57BL/6 mice was then analyzed.
RESULTS: The CP binds to the surface of B16-F1 melanoma cells; this binding can be inhibited by lactose at a concentration of 0.15 M. Intravenous injection of the murine B16-F1 melanoma cells with the natural CP resulted in a significant increase (up to threefold) in the appearance of tumor colonies in the lung and in increased homotypic aggregation properties of the cells, while injection of MCP significantly decreased B16-F1 experimental metastasis (greater than 90%).
CONCLUSIONS: Tumor galactoside-binding proteins mediate cellular recognition by linking oligosaccharides with terminal D-galactoside residues on adjacent cells. Successful interference with such a process with MCP may lead to a reduced ability to form tumor cell emboli and metastasis. IMPLICATIONS: These findings imply that the galactose-containing carbohydrate side chains of CP might mimic or compete with the natural ligand(s) of the tumor galactoside-binding protein (gal-lectin) and thus affect cellular interactions relevant for metastasis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538421     DOI: 10.1093/jnci/84.6.438

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  31 in total

Review 1.  Galectin-3 and cancer stemness.

Authors:  Pratima Nangia-Makker; Victor Hogan; Avraham Raz
Journal:  Glycobiology       Date:  2018-04-01       Impact factor: 4.313

2.  Galectin-3 induces endothelial cell morphogenesis and angiogenesis.

Authors:  P Nangia-Makker; Y Honjo; R Sarvis; S Akahani; V Hogan; K J Pienta; A Raz
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  The inhibitory effects of a rhamnogalacturonan I (RG-I) domain from ginseng pectin on galectin-3 and its structure-activity relationship.

Authors:  Xiaoge Gao; Yuan Zhi; Lin Sun; Xiaoxia Peng; Tao Zhang; Huiting Xue; Guihua Tai; Yifa Zhou
Journal:  J Biol Chem       Date:  2013-10-07       Impact factor: 5.157

Review 4.  Nuclear transport of galectin-3 and its therapeutic implications.

Authors:  Tatsuyoshi Funasaka; Avraham Raz; Pratima Nangia-Makker
Journal:  Semin Cancer Biol       Date:  2014-03-19       Impact factor: 15.707

5.  Migration and proliferation of cancer cells in culture are differentially affected by molecular size of modified citrus pectin.

Authors:  Samira Bernardino Ramos do Prado; Tânia Misuzu Shiga; Yosuke Harazono; Victor A Hogan; Avraham Raz; Nicholas C Carpita; João Paulo Fabi
Journal:  Carbohydr Polym       Date:  2019-02-04       Impact factor: 9.381

6.  Antimetastatic pectic polysaccharide from Decalepis hamiltonii; galectin-3 inhibition and immune-modulation.

Authors:  Sathisha U Venkateshaiah; Mallikarjuna S Eswaraiah; Harish Nayaka M Annaiah; Shylaja M Dharmesh
Journal:  Clin Exp Metastasis       Date:  2017-02-03       Impact factor: 5.150

7.  Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions.

Authors:  H Inohara; A Raz
Journal:  Glycoconj J       Date:  1994-12       Impact factor: 2.916

8.  Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model.

Authors:  Hai-Ying Liu; Zhi-Liang Huang; Guo-Hua Yang; Wei-Qun Lu; Nan-Rong Yu
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

Review 9.  Galectin-3 and metastasis.

Authors:  Yukinori Takenaka; Tomoharu Fukumori; Avraham Raz
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

10.  Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine.

Authors:  D Shrayer; H Bogaars; V J Hearing; A Maizel; H Wanebo
Journal:  Cancer Immunol Immunother       Date:  1995-05       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.